-
Pesquisa liderada por Pedro Cruz mostra que diferentes heranças genômicas configuram formas específicas de manifestação da doença
A divergência entre as heranças genéticas de grupos distintos de portadores de anemia falciforme foi a motivação do estudo de Pedro Rodrigues Sousa da Cruz, do Laboratório de Genética Humana do Centro de Biologia Molecular e Engenharia Genética (CBMEG) da Unicamp, [...]
-
A pesquisa que foi liderada por Pedro Cruz mostra que diferentes heranças genômicas configuram formas específicas de manifestação da doença
A divergência entre as heranças genéticas de grupos distintos de portadores de anemia falciforme foi a motivação do estudo de Pedro Rodrigues Sousa da Cruz, do Laboratório de Genética Humana do Centro de Biologia Molecular e Engenharia Genética (CBMEG) da [...]
-
A divergência entre as heranças genéticas de grupos distintos de portadores de anemia falciforme foi a motivação do estudo de Pedro Rodrigues Sousa da Cruz, do Laboratório de Genética Humana do Centro de Biologia Molecular e Engenharia Genética (CBMEG) da Unicamp, publicado recentemente na revista Scientific Reports. Em cooperação com outros pesquisadores que se dedicam a essa mesma linha de pesquisa, Pedro analisou pacientes [...]
-
Pesquisa mostra que diferentes heranças genômicas configuram formas específicas de manifestação da doença
A divergência entre as heranças genéticas de grupos distintos de portadores de anemia falciforme foi a motivação do estudo de Pedro Rodrigues Sousa da Cruz, do Laboratório de Genética Humana do Centro de Biologia Molecular e Engenharia Genética (CBMEG) da Unicamp, publicado recentemente na [...]
-
The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.
This point is made in a comprehensive review of the main research findings regarding sickle disease published in Nature Reviews Disease Primers and signed by experts affiliated with [...]
-
The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.
This point is made in a comprehensive review of the main research findings regarding sickle disease published in Nature Reviews Disease Primers and signed by experts affiliated with [...]
-
The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.
This point is made in a comprehensive review of the main research findings regarding sickle disease published in Nature Reviews Disease Primers and signed by experts affiliated with [...]
-
The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.
This point is made in a comprehensive review of the main research findings regarding sickle disease published in Nature Reviews Disease Primers and signed by experts affiliated with [...]
-
Article signed by researchers affiliated with institutions in the US, UK, Ghana and Brazil highlights recent progress in diagnosis and treatment but warns that more screening of newborns is needed
The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases [...]
-
The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.
This point is made in a comprehensive review of the main research findings regarding sickle disease published in Nature Reviews Disease Primers and signed by experts affiliated with [...]
